Figure 4.
Figure 4. Effects of various inhibitors in the aPTT assay. Pooled human plasma (180 μL) was mixed with 20 μL of various inhibitors to attain the indicated final concentrations. Clotting times were determined with an ACL 200 coagulation analyzer. The plasma with control buffer had an aPTT of 40.7 seconds. □ indicates TAP-ANV; ○, ANV-KAPP; ⋄, ANV-KKTFPI; ▵, ANV-6L15; ×, ANV; +, 6L15; •, TAP; ♦, TFPI1-160.

Effects of various inhibitors in the aPTT assay. Pooled human plasma (180 μL) was mixed with 20 μL of various inhibitors to attain the indicated final concentrations. Clotting times were determined with an ACL 200 coagulation analyzer. The plasma with control buffer had an aPTT of 40.7 seconds. □ indicates TAP-ANV; ○, ANV-KAPP; ⋄, ANV-KKTFPI; ▵, ANV-6L15; ×, ANV; +, 6L15; •, TAP; ♦, TFPI1-160.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal